Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) that mimics the action of the natural hormone GLP-1 in the body. GLP-1 is released by the intestines in response to food intake and helps regulate blood sugar levels by stimulating insulin release and reducing glucagon secretion. Semaglutide is administered as an injectable medication.
Tirzepatide is another GLP-1 RA, but it also has a dual action as it simultaneously acts on the glucose-dependent insulinotropic polypeptide (GIP) receptor. GIP is another hormone involved in regulating blood sugar levels after eating. By targeting both GLP-1 and GIP receptors, tirzepatide is designed to provide more potent blood sugar control.
We only prescribe Semaglutide and Tirzepatide for weight loss. However, they both are also used to improve glycemic control in adults with type 2 diabetes. Semaglutide is also being studied off-label for alcohol addiction and inflammatory conditions.
Semaglutide and Tirzepatide both produce amazing weight loss results by moderating your digestive process and cravings. Specifically, they are responsible for the following effects:
They are very similar drugs, used for the same conditions. Tirzepatide is a newer and slightly more effective GLP-1 for weight loss. However, it is also more expensive. We generally recommend patients start on Semaglutide to save money. If Patients max-out on their Semaglutide dosing and have not yet reached their target weight, we will recommend switching to Tirzepatide.
Semaglutide, like any medication, may cause side effects in some individuals. The side effects can vary from person to person, and not everyone will experience them. These side effects are usually mild and may improve over time as the body adjusts to the medication. We also can provide additional medications to treat them.
Common side effects of semaglutide may include:
No, there is no evidence to suggest that Semaglutide or Tirzepatide are addictive. Semaglutide and Tirzepatide are not classified as addictive substances, nor do they have any known properties that would lead to addiction or dependence.
Weight loss is a complex process influenced by various factors, including genetics, lifestyle, and individual metabolism. For many people, maintaining weight loss over the long term can be challenging, regardless of the method used to achieve it – whether through lifestyle changes, medication, or other interventions.
When considering the use of Semaglutide for weight loss, it’s essential to work closely with a healthcare professional who can provide guidance and support throughout the weight loss journey. They can help design a comprehensive plan that includes not only the use of medication but also lifestyle changes, such as adopting a balanced diet, increasing physical activity, and establishing healthy habits.
Yes, both Semaglutide and Tirzepatide can cause overdose if taken in excessive amounts. These medications are prescribed at specific doses based on individual needs and medical conditions. Taking more than the prescribed dose can lead to serious health consequences such as:
If you suspect an overdose or experience any concerning symptoms after taking Semaglutide or Tirzepatide, seek immediate medical attention or visit the nearest emergency room.
No, Semaglutide and Tirzepatide are used off-label for weight loss and are provided by a special pharmacy that distributes from a separate supply than what is prescribed to patients with diabetes. The brand name version of Semaglutide – Ozempic – is prescribed for people with diabetes.
No, neither semaglutide nor tirzepatide was available over the counter. Both medications are prescription drugs, meaning you cannot obtain them without a valid prescription from a licensed healthcare provider.
Yes. Semaglutide and Tirzepatide are generally safe to use in combination with almost all other medications. They can also be combined with other appetite suppressants for maximum effects. Always inform your healthcare provider about any medications, supplements, or herbal products you are taking before starting Semaglutide, Tirzepatide, or any new medication.
They both work extremely quickly! The effects on the moderation of appetite and digestion will be noticed within hours of receiving the injection. The average amount of weight a patient loses in the first month is around 10lbs. If your appetite is unchanged, you may need a higher dose to get the desired results.
There are no dietary restrictions but we encourage a healthy, well-balanced diet while being on Semaglutide and Tirzepatide. While you do not need to regulate which types of food you eat on these drugs, there are some considerations for how you eat. We would recommend the following:
Semaglutide and Tirzepatide are not recommended for use during pregnancy or while breastfeeding. Both medications are pregnancy category B, which means there may be some animal studies showing no risk to the fetus, but there are no adequate and well-controlled studies in pregnant women.
It’s essential for pregnant or breastfeeding individuals to work closely with their healthcare providers to manage their condition safely. During pregnancy, blood sugar control is crucial for both the health of the mother and for the developing baby and thus it is not recommended, since both drugs affect blood sugar levels.
The duration of and dosage of treatment with Semaglutide and Tirzepatide may vary based on individual health factors as well as the response to the medication. You can work closely with our medical staff to ensure that the treatment plan is tailored to your specific health needs and goals.